IP Library › Granted Patent US 9,758,592
Granted Patent B2
US 9,758,592 · App. 14/079,686 · Granted Sep 12, 2017

Recombinant cell surface capture proteins

Inventors: Dipali Deshpande (White Plains, NY); Gang Chen (Yorktown Heights, NY); Darya Burakov (Yonkers, NY); James Fandl (LaGrangeville, NY); Thomas Aldrich (Yorktown Heights, NY); Vishal Kamat (Bergenfield, NJ)
Assignee: Regeneron Pharmaceuticals, Inc.
C07K16/4258C07K16/22C07K16/2863C07K16/42C07K2317/31C07K2317/526C07K2317/64C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,758,592
App. No.
14/079,686
Granted
Sep 12, 2017
Kind
B2
Abstract

Recombinant cell surface capture proteins and detection molecules that are useful for isolating and detecting cells that produce a secreted heterodimeric protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 domain are provided. Recombinant cell surface capture proteins and detection molecules that isolate and detect bispecific antibodies are also provided. The invention also provides recombinant antigen-binding proteins that are capable of recognizing and binding to proteins of interest that contain a CH3 domain and/or a modified CH3 domain, such as a CH3 domain with or without amino acid substitutions at H95 and Y96 (IMGT).

Claims (8)

1. A recombinant antigen-binding protein that binds a human IgG1-Fc domain, a human IgG2-Fc domain, or a human IgG4-Fc domain, wherein the antigen-binding protein comprises a heavy chain CDR-1 (HCDR-1) having the amino acid sequence of SEQ ID NO:27, an HCDR-2 having the amino acid sequence of SEQ ID NO:28, an HCDR-3 having the amino acid sequence of SEO ID NO:29, and a light chain variable region having the amino acid sequence of SEO ID NO: 16.

2. The recombinant antigen-binding protein of claim 1 , wherein the antigen-binding protein binds a polypeptide comprising an amino acid sequence of SEQ ID NO:26.

3. The recombinant antigen-binding protein of claim 2 , wherein the antigen-binding protein binds the polypeptide with a KD of less than about 40 nM as measured in a surface plasmon resonance assay.

4. The recombinant antigen-binding protein of claim 2 , wherein the antigen-binding protein comprises an HCVR having an amino acid sequence that is at least 95% identical to SEQ ID NO:15.

5. The recombinant antigen-binding protein of claim 4 , wherein the antigen-binding protein comprises an HCVR having the amino acid sequence of SEQ ID NO:15.

6. The recombinant antigen-binding protein of claim 4 , wherein the antigen-binding protein is an ScFv fusion protein comprising (a) a heavy chain variable domain comprising an amino acid sequence that is at least 95% identical to SEQ ID NO:15, and (b) a membrane anchor domain comprising an amino acid sequence that is at least 95% identical to SEQ ID NO:17 or SEQ ID NO:21.

7. The recombinant antigen-binding protein of claim 6 , wherein the antigen-binding protein is an ScFv fusion protein comprising a heavy chain variable domain that has an amino acid sequence identical to SEQ ID NO:15.

8. The recombinant antigen-binding protein of claim 7 , wherein the antigen-binding protein is an ScFv fusion protein comprising the amino acid sequence of SEQ ID NO:19.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2014
From: DESHPANDE, DIPALI; CHEN, GANG; BURAKOV, DARYA; FANDL, JAMES; ALDRICH, THOMAS; KAMAT, VISHAL
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 032561/0780 →
Continuity (2)
Provisional Application 61726040 · Nov 14, 2012
Related Publication 20140134719A1 · May 15, 2014